Can you believe they really said this…2

Oh yes – there’s more…

Corporate responsibility is not just a job for selected people at GSK, it defines the way we do business. Our ten corporate responsibility principles set thestandard for everyone, since responsible business is only a reality if it is practised by all employees at all times.
Christopher Gent
GlaxoSmithKline Chaiman
Jean-Pierre Garnier
GlaxoSmithKline CEO
GlaxoSmithKline 2004 “Corporate Responsibility Report”

The overwhelming view of independent medical experts and regulatory bodies around the world who have seen the data, is that Seroxat has a well established safety profile and is an effective treatment with experience in tens of millions of patients worldwide since launch in the UK over ten years ago.
Dr. Alastair Benbow
Head of European Psychiatry for GlaxoSmithKline 10/10/2002

Human behavior is we know so little about it, and therefore, to try to speculate on a mechanism for human behavior is very difficult.
Dr. Tadataka Yamada
Chairman of Research and Development GlaxoSmithKline 1/24/2001

Sometimes a system indeed hinders your rise up the ladder but you also have to accept personal responsibility. That translates into realizing that it’s not always someone else’s fault that you didn’t get promoted. You have to ask some serious questions of yourself before you point the finger at someone else. Ask yourself, `What have I done?’ ‘What is my role in this?’ ‘What am I willing to do?’
Dr. David Wheadon
Senior Vice President
GlaxoSmithKline Regulatory Affairs and Product Professional Services
10/26-27/1995

If we meet the test of our highest purpose nothing less than making historic contributions to human welfare then we will surely meet our important responsibilities to other GlaxoSmithKline stakeholders, to the investors who put their trust in our performance, to the communities in which we operate, to our colleagues and to ourselves.
Dr. Tadataka Yamada
Chairman of Research and Development
GlaxoSmithKline from GSK’s web site

We are all in favour of this being scrutinized all the time, because it is not in our interests to have a product on the market that is not safe or effective.
Jean-Pierre Garnier
Chief Executive Officer
GlaxoSmithKline 2/15/2002

I think fundamentally the public needs to be reassured that multinational companies and globalisation are not bad quite the reverse.
Jean-Pierre Garnier
Chief Executive Officer
GlaxoSmithKline
2/18/2003

We take the safety of our medicines extremely seriously….
Dr. Alastair Benbow
GlaxoSmithKline’s European Medical Director
Source: GSK’s web site 2004

First of all let me say that we, as a manufacturer of pharmaceutical products and vaccines, take any report of an adverse event on any of our products, seriously.
Dr. David Wheadon
Senior Vice President
GlaxoSmithKline Regulatory Affairs and Product Professional Services
1/31/2001

If you pay peanuts you get monkeys and we cannot have monkeys running this company.
Jean-Pierre Garnier
Chief Executive Officer
GlaxoSmithKline
1999

9 Responses to “Can you believe they really said this…2”

  1. Matthew Holford Says:

    “Human behavior is we know so little about it, and therefore, to try to speculate on a mechanism for human behavior is very difficult.
    Dr. Tadataka Yamada
    Chairman of Research and Development GlaxoSmithKline 1/24/2001”

    Erm, Dr Yamada? Are you human? If so, then you know all there is to know about human behaviour. It’s really not that complex, once you get your eye in.

    You’d like it to be a mystery, so that you can carry on pretending depression and other “mental illness” is inexplicable, in order to flog people more drugs. But it’s not a mystery, now is it? It’s all about identifying possibility, or not. Remember that, and you’ll go far, my son.

  2. Matthew Holford Says:

    “If you pay peanuts you get monkeys and we cannot have monkeys running this company.
    Jean-Pierre Garnier
    Chief Executive Officer
    GlaxoSmithKline
    1999”

    That’s right. And that’s precisely why I’m unemployed: nobody could afford me.

  3. Matthew Holford Says:

    If we meet the test of our highest purpose nothing less than making historic contributions to human welfare then we will surely meet our important responsibilities to other GlaxoSmithKline stakeholders, to the investors who put their trust in our performance, to the communities in which we operate, to our colleagues and to ourselves.
    Dr. Tadataka Yamada
    Chairman of Research and Development
    GlaxoSmithKline from GSK’s web site

    Oh, you want to play the “if, then” game, do you? Well, if you were meeting the test of highest purpose, then nobody would be complaining. Or if one was pursuing highest purpose, then when people reported an issue, one would engage with them, until they were satisfied that a solution had been accomplished.

    I think you might do well to establish what your highest purpose is, and be sure that that is understood by everybody. In that way, everybody would understand what you were trying to achieve. Personally, I don’t see that ignoring people, who believe that they have an issue with your product, demonstrates the acme of any particular goal, to be honest.

    Matt

  4. Matthew Holford Says:

    Corporate responsibility is not just a job for selected people at GSK, it defines the way we do business. Our ten corporate responsibility principles set thestandard for everyone, since responsible business is only a reality if it is practised by all employees at all times.
    Christopher Gent
    GlaxoSmithKline Chaiman
    Jean-Pierre Garnier
    GlaxoSmithKline CEO
    GlaxoSmithKline 2004 “Corporate Responsibility Report”

    I thought that you might be interested to know that GSK has a Compliance Officer, whose name is Simon Bicknell. He may be contacted at .

    This is not a big secret, although I’m very interested to discover the contacts of anybody from GSK, on a public website, given its secrecy, generally. However, his details are to be found in GSK’s Guide to Business Conduct, 4th Edn, which was apparently published in August, 2006:

    http://www.gsk.com/responsibility/Downloads/Employee-guide-2004.pdf

    I’m going to ask him what his opinion is of the conduct of the author of that 1998 memo. The views thus expressed appear to support the commission of a criminal offence (ie, not disclosing trials data). I’ll bet he was really angry, don’t you?

    Matt

  5. Matthew Holford Says:

    Oops. Simon’s ‘mail address doesn’t appear to have printed. It is Simon.M.Bicknell@gsk.com.

  6. truthman30 Says:

    The overwhelming view of independent medical experts and regulatory bodies around the world who have seen the data, is that Seroxat has a well established safety profile and is an effective treatment with experience in tens of millions of patients worldwide since launch in the UK over ten years ago.
    Dr. Alastair Benbow
    Head of European Psychiatry for GlaxoSmithKline 10/10/2002

    What Mr Benbow fails to see here is that the boy who cried wolf has actually been eaten by the wolf…
    He just hasn’t realized it yet…

  7. truthman30 Says:

    First of all let me say that we, as a manufacturer of pharmaceutical products and vaccines, take any report of an adverse event on any of our products, seriously.
    Dr. David Wheadon
    Senior Vice President
    GlaxoSmithKline Regulatory Affairs and Product Professional Services
    1/31/2001

    As serious as a free lunch….?
    Or as serious as a deformed baby?…
    Or as serious as a paycheck?…
    Or as serious as a suicide….?

  8. truthman30 Says:

    The overwhelming view of independent medical experts and regulatory bodies around the world who have seen the data, is that Seroxat has a well established safety profile and is an effective treatment with experience in tens of millions of patients worldwide since launch in the UK over ten years ago.
    Dr. Alastair Benbow
    Head of European Psychiatry for GlaxoSmithKline 10/10/2002

    I wonder which independent experts he was refering to…Keller, Ryan, Pollock…?
    Because as far as I am aware , these experts were not as independent as we had been led to believe…
    On the contrary, any “truly independent study” I have read…
    and by that i mean, NOT ones funded by Glaxo, Seroxat’s safety profile left a hell of a lot to be desired…
    In other words , it didn’t perform so well…
    I suppose we could consider a trial to be a failure if most of the participants dropped out or couldn’t tolerate the drug because it was obviously too defective and toxic… this seems to be something which they consistantly seem to overlook.. strange that…

  9. Matthew Holford Says:

    “I’m going to ask him what his opinion is of the conduct of the author of that 1998 memo. The views thus expressed appear to support the commission of a criminal offence (ie, not disclosing trials data). I’ll bet he was really angry, don’t you?”

    That ‘mail address must be out-of-date (yeah, that’d be it), because Simon hasn’t replied.

    Matt


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s